Please find attached correspondence HERE from Aidan Dawson, CEO of the Public Health Agency. The correspondence provides an update on the COVID-19 Spring Booster Vaccination Programme for Care Home Residents.
Summary:
The contribution of pharmacies involved in delivering the COVID-19 spring booster vaccination programme to care home residents is acknowledged.
Thanks are extended for the role played by pharmacy in ensuring over 10,000 residents have been vaccinated so far.
The original end date for the programme was 31 May 2022 but has now been extended to 15 June 2022 to allow further time for pharmacies, if they wish, to continue to vaccinate eligible care home residents, where appropriate.
Those pharmacies involved in the Spring Booster Care Home Vaccination programme are asked to support this final opportunity to ensure that this vulnerable group are vaccinated in this time.
Action:
Review the attached correspondence and discuss with your pharmacy teams.
If you wish to proceed to vaccinate care home residents into June, please make the necessary arrangements with the home.
If you are unable to extend the programme, please advise the care home accordingly so that Trust teams can implement plans to offer vaccinations to residents who previously missed your clinics.
The Community Vaccination Service Update also issued on 31 May 2022 and is available here.
Should you have any queries please do not hesitate to speak to a member of the team.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The final update of concessionary prices were granted today for May 2022:
Drug
Pack Size
Concessionary Price
Aciclovir 400mg tablets
56
£3.20
Aciclovir 800mg tablets
35
£3.21
Aripiprazole 10mg tablets
28
£1.32
Benzydamine 0.15% oromucosal spray sugar free
30
£2.95
Bisacodyl 10mg suppositories
12
£2.77
Chlorpromazine 50mg tablets
28
£10.51
Clonidine 25microgram tablets
112
£11.50
Co-dydramol 10mg/500mg tablets
30
£2.29
Co-dydramol 10mg/500mg tablets
100
£7.63
Cyclizine 50mg/1ml solution for injection ampoules
Living well social media assets and schedule to support Know Check Ask campaign are now available at Social Media schedule (hscni.net).
As part of your Living Well resources, you will have received a Know Check Ask window sticker that was not referenced in previous SPPG correspondence. This is an additional resource, however it is not a replacement for display of the posters and as per your Living Well contract, posters must be displayed in at least one window unit of the pharmacy premises for the full duration of the campaign.
Serious Shortage Protocols (SSPs) May 2022 Update
To support contractors in managing the current SSPs arrangements, CPNI have produced a Serious Shortage Protocols (SSPs) May Update which can be found HERE.
Please bring this to the attention of your pharmacy team(s).
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
Dear Contractor
Please find attached correspondence HERE from Professor Sir Michael McBride, Chief Medical Officer; Ms Maria McIlgorm, Chief Nursing Officer and Mrs Cathy Harrison, Chief Pharmaceutical Officer.
SUMMARY
The eligibility criteria for COVID-19 Spring Booster Vaccination has been extended by one month and therefore those who will turn 75 years old by 30 June 2022 (i.e. those born before 30 June 1947), can receive a spring booster dose.
Any patient who turns 75 during June and requests vaccination, can receive their vaccine via a participating community pharmacy.
Contractors should contact their local SPPG office in the first instance should further information be required.
Please do not hesitate to contact CPNI office should you require any further information.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Please find attached correspondence HERE from Cathy Harrison, Chief Pharmaceutical Officer.
SUMMARY
Serious shortage protocols (SSPs) under the Human Medicines Regulations 2012 (HMRs) are an additional tool to manage and mitigate medicines shortages.
An SSP enables community pharmacists to supply a specified medicine in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber.
In response to continued high demand and disruption to the supply of some HRT medicines, DHSC has now issued a further ten new SSPs HERE to allow community pharmacists to consider different options to enable continued supply of HRT medicines to mitigate the ongoing supply disruptions affecting five HRT medicines.
These SSPs came into operation in all parts of the UK on 19 May 2022 and all have an expiry date of 19 August 2022.
Pharmacists will need to call on their clinical expertise to determine which SSP is the most appropriate to use in each scenario and to counsel patients on any changes made to their treatment and what it means for their medicine regimen.
Community pharmacists should use their professional skill and judgement to decide whether it is reasonable and appropriate to substitute or limit the patient’s prescribed order for a supply under these active SSPs.
Pharmacists should be aware that where a therapeutic equivalent is supplied under an SSP then the patient’s prescriber should be notified.
Pharmacists should also refer to the Operational Guidance on Serious Shortage Protocols, which is available HERE.
Contractors should also ensure that their dispensary teams are aware of these new protocols.
Contractors should contact their local SPPG office in the first instance should further information be required.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The second update of concessionary prices were granted for May 2022:
Drug
Pack Size
Concessionary Price
Amoxicillin 250mg/5ml oral suspension sugar free
100
£1.68
Co-tenidone 100mg/25mg tablets
28
£1.42
Exemestane 25mg tablets
30
£19.91
Famotidine 20mg tablets
28
£16.25
Famotidine 40mg tablets
28
£28.54
Febuxostat 80mg tablets
28
£3.17
Flecainide 100mg tablets
60
£4.25
Frovatriptan 2.5mg tablets
6
£3.09
Isotretinoin 20mg capsules
30
£16.15
Losartan 50mg tablets
28
£1.71
Midazolam 10mg/2ml solution for injection ampoules
10
£6.20
Oxybutynin 5mg tablets
56
£1.55
Rivastigmine 3mg capsules
28
£5.21
Ropinirole 250microgram tablets
12
£3.35
Ropinirole 2mg tablets
28
£17.50
Sodium bicarbonate 500mg capsules
56
£3.76
Tolterodine 1mg tablets
56
£2.48
Tolterodine 2mg tablets
56
£3.12
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.
Concessionary prices are also published on the CPNI website.
Kind regards
SENT ON BEHALF OF DR. GARETH C. GILVARY Governance & Support Pharmacist
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
